Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SCN4B mRNA | affects cotreatment|increases expression | 18164116
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SCN4B mRNA | increases expression | 20382639
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SCN4B mRNA | affects cotreatment|increases expression | 18164116
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of SCN4B mRNA | decreases expression | 16221955
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SCN4B mRNA | increases expression | 18301758
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SCN4B mRNA | increases expression | 20159946
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.31 | 15322242 14514962 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
7.44 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.44 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
20.17 | 16434500 18056438 19052882 17162532 19061943 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
20.17 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
20.17 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.87 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.87 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.94 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.94 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
1.87 | 18785209 18494052 18393292 19107877 19701751 18978308 20214788 20101231 21159647 19418558 16935385 16681979 11831363 19822196 16288022 16878318 17173139 20512989 3581430 20007298 10672840 20524982 17978847 20727157 17138121 18971187 20935162 19383236 19519916 16698587 16807293 17162532 19335982 18665156 20084675 20432363 19394651 16328049 19539802 18056438 17055752 18788625 3084413 10737359 16569478 18691550 16779866 16502159 18506893 16540662 19171122 16830150 19919837 17761372 19052882 19208518 20514400 18210153 17428255 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.38 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
7.38 | 21159647 2727394 7505956 17174075 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
10.29 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
10.29 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.05 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 15668235 8697196 15340226 12621046 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.43 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.43 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.98 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.98 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.99 | 11462148 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
13.42 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
13.42 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
13.42 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 10568697 9294722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.64 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.13 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.78 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.78 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.47 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
17.04 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
17.04 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
17.04 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 16354765 15340226 8697196 18606429 16959395 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
4.10 | 12083418 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.00 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
9.23 | 18785209 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
9.23 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.23 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.82 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.69 | 8812269 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.98 | 20032147 18407596 18665156 18522880 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.21 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.21 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.16 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
15.34 | 21295105 19389873 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
15.34 | 19427195 18648771 2422723 19499222 20118626 20492335 19090486 18644402 20583210 20405173 19551842 12771043 18978307 20137499 20501860 18754104 20434301 19254457 19850985 19833225 19255062 10737359 16942905 19690152 15885732 19812893 19294768 19426721 19642983 19073162 2862719 21278145 19996281 21047994 21167192 19256749 21071580 12112319 20101389 19638242 18977376 15175105 20452335 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
15.34 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
15.34 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
15.34 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
10.94 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.94 | 16842330 18544905 2563599 3124819 19126423 18775883 18164116 18079962 19539802 17942915 18282651 18093689 19004024 18253720 17854601 19009564 9362446 19519916 17174075 16267830 21159647 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.94 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
marker/mechanism |
|
| |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.33 | 20512841 20970405 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.33 | 19555203 11884234 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.67 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.08 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.59 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.61 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.64 | 20387270 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
5.37 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.51 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.84 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
11.26 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
11.26 | 11896295 11222880 11118676 11399792 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.17 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.22 | 7505956 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |